4:56 PM
 | 
Feb 12, 2018
 |  BC Extra  |  Company News

Management tracks: Cytokinetics, Surface Oncology

Musculoskeletal company Cytokinetics Inc. (NASDAQ:CYTK) appointed ex-FDA Commissioner Robert Califf to its board of directors. Califf is vice chancellor for health data science at Duke Health and director of the Center for Health Data Science at Duke University (Durham, N.C.). He served as FDA commissioner from February 2016 through January 2017.

Immunotherapy company Surface Oncology Inc. (Cambridge, Mass.) promoted Jeff Goater to CEO from chief business officer.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) hired Marion McCourt as SVP and head of commercial. She was president and COO at Axovant Sciences Ltd. (NASDAQ:AXON).

Gastrointestinal company Ardelyx Inc. (NASDAQ:ARDX) said CSO Jeremy Caldwell is stepping down, effective Feb. 16. Caldwell will become CEO at an undisclosed San Diego-based biotech start-up.

Acceleron Pharma Inc. (NASDAQ:XLRN) hired Sujay Kango as chief commercial officer. He was VP of global commercial development for oncology at AbbVie Inc. (NYSE:ABBV).

City of Hope (Duarte, Calif.) hired Jennifer Parkhurst as CFO. Parkhurst was a partner for pharma and life sciences operations consulting and strategy practice at PricewaterhouseCoopers.

Immuno-oncology company ImmunoMet Therapeutics Inc. (Houston, Texas) hired Vincent O'Neill as CMO and Allan Shaw as CFO. O'Neill was CMO at Mirna Therapeutics Inc., which Synlogic Inc. (NASDAQ:SYBX) acquired. Shaw was CFO at Syndax Pharmaceuticals Inc. (NASDAQ:SNDX).

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD